Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06118632
Other study ID # CW005
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 22, 2023
Est. completion date May 30, 2025

Study information

Verified date October 2023
Source Chelsea and Westminster NHS Foundation Trust
Contact Arnold Xhikola
Phone 00442033152560
Email arnold.xhikola1@nhs.net
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study plans to monitor around 300 people from different hospitals with COPD for a period of 3 months after they are discharged from the hospital using a smartphone app and a Fitbit device. This device can passively track certain health metrics; this way the research team can research whether it is possible to identify the early warning signs of a decline in health by using these ongoing measurements of vital signs and symptoms. This could allow doctors to intervene early and potentially prevent further deterioration in health decline and hospital admission altogether. The study seeks to investigate how similar these physiological measurements are when collected in the real world rather than just in the hospital setting, and what influence environmental factors have on a patient's health and experience of their condition.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date May 30, 2025
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 120 Years
Eligibility Inclusion Criteria: - Aged 18 or over. - Diagnosis of COPD, currently admitted to hospital and clinically stable with a confirmed acute exacerbation of COPD. - Ownership of a smartphone (iOS version 13 or above, Android version 8 or above). - Able to provide informed consent to participate in study. Exclusion Criteria: - Patients who require less than 24 hours in hospital at initial visit. - Patients deemed unlikely to cooperate with study requirements. - Patients with implantable devices. - Patient not felt to be suitable for research enrolment by admitting clinical team. - Patients requiring non-invasive ventilation or deemed to have a life-expectancy of less than 90 days following discharge.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observational
Observational

Locations

Country Name City State
United Kingdom Stoke Mandeville Hospital Aylesbury
United Kingdom Royal Sussex County Hospital Brighton
United Kingdom Chelsea and Westminster Hospital NHS Foundation Trust London
United Kingdom Nottingham University Hospitals Nottingham

Sponsors (1)

Lead Sponsor Collaborator
Chelsea and Westminster NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the volume and quality of the data collected in terms of: Total number of subjects: number of subjects who completed the on boarding stage of the study 3 months
Primary To assess the volume and quality of the data collected in terms of: Dropout rate: proportion of subjects who dropped out (withdrew from study or stopped using the app/connected device prior to the off-boarding process or had to exit the trial due to deterioration) 3 months
Primary To assess the volume and quality of the data collected in terms of: Median time to dropout, where time to dropout is the number of days between subject's enrolment date and drop-out date (either date of withdrawal/exit from the study or date when subject stopped using the app and connected device entirely) 3 months
Primary To assess the volume and quality of the data collected in terms of: Number of participants who provided passive measurements for minimum of 50% of the study period 3 months
Primary To assess the volume and quality of the data collected in terms of: Number of participants who provided minimum of 33% of measures requiring active input from user 3 months
Primary To assess the volume and quality of the data collected in terms of: Data completeness: proportion of missing and total number of data points 3 months
Primary To assess the volume and quality of the data collected in terms of: Data consistency across sources: where similar information is recorded in multiple modules (e.g., breathlessness scale and symptom tracker), proportion of records in which consistent answers were provided will be reported 3 months
Primary To assess the volume and quality of the data collected in terms of: Proportion of data within admissible value range, where admissible value range will be determined based on literature or clinical guidance 3 months
Primary To assess the volume and quality of the data collected in terms of: Similarity of collected data distribution to expected data distribution, where expected data distribution will be determined based on literature and similarity of the two distributions evaluated by a suitable statistical technique (e.g., Kolmogorov-Smirnov test) 3 months
Secondary To ascertain whether marked physiological events can be detected using smartphone and connected device sensors in a remote setting. Using clinical endpoints such as exacerbation events and readmission to predict exacerbation episodes 3 months
Secondary To assess the relationship between patient-generated data gathered from smartphone and connected devices and conventional clinical measures at point of readmission. The prediction of physiological measures at readmission (e.g., pulse rate, respiratory rate, pH, FBC, CRP, and CXR appearance) can be addressed as a regression task and evaluated with metrics such as root mean squared error (RMSE). 3 months
Secondary To assess the relationship between patient-generated data gathered from smartphone and connected devices and patient reported functional status. The prediction of reported outcome measures (CAT; EQ-5D; SGRQ-C) can also be addressed as a regression task, evaluated with RMSE, as detailed above. 3 months
Secondary To assess the change in passively generated data at the time of further community intervention (HCP review and/or prescription for corticosteroids or antibiotics). Acquired physiological and environmental data before and after community intervention will be compared using appropriate statistical tests to identify whether effects of these interventions were detectable in the acquired physiological data. We will also attempt to use machine learning models for the classification tasks of predicting corticosteroids, antibiotics, or HCP review outcome) using the physiological and environmental data in the time window prior to the specified community intervention outcome. 3 months
Secondary To evaluate the usability and acceptability of patient-generated data gathered from smartphone and connected devices in a remote setting in patients with COPD. Summary of the outcomes measured in the HCP mHealth app usability questionnaire (MAUQ) and other app analytics will be generated using standard summary statistics measures (mean/median, standard deviation, confidence intervals). This data will be assessed in relation to app and usage analytics such as compliance rate, drop-out rate, and device wear time. 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Recruiting NCT03250000 - Changes in Microcirculation and Functional Status During Exacerbation of COPD N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A
Completed NCT04170361 - The Effect of Incentive Spirometry Added to Routine Physiotherapy Program on Hemodynamic Responses and Hospital Stay in Patients With COPD Exacerbation N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Not yet recruiting NCT03296215 - Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals N/A
Completed NCT02912689 - NIV - NAVA vs NIV - PS for COPD Exacerbation N/A
Completed NCT03003702 - Domiciliary Monitoring to Predict Exacerbations of COPD N/A
Recruiting NCT02264483 - Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile. N/A
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Recruiting NCT02065921 - Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
Completed NCT04880486 - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I
Recruiting NCT04638920 - Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
Not yet recruiting NCT05897125 - Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients N/A
Recruiting NCT06304207 - Telehealth and Onsite Maintenance Exercise in COPD N/A